Please use this identifier to cite or link to this item:
https://doi.org/10.1038/srep00667
DC Field | Value | |
---|---|---|
dc.title | Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile | |
dc.contributor.author | Kaddurah-Daouk, R. | |
dc.contributor.author | Yuan, P. | |
dc.contributor.author | Boyle, S.H. | |
dc.contributor.author | Matson, W. | |
dc.contributor.author | Wang, Z. | |
dc.contributor.author | Zeng, Z.B. | |
dc.contributor.author | Zhu, H. | |
dc.contributor.author | Dougherty, G.G. | |
dc.contributor.author | Yao, J.K. | |
dc.contributor.author | Chen, G. | |
dc.contributor.author | Guitart, X. | |
dc.contributor.author | Carlson, P.J. | |
dc.contributor.author | Neumeister, A. | |
dc.contributor.author | Zarate, C. | |
dc.contributor.author | Krishnan, R.R. | |
dc.contributor.author | Manji, H.K. | |
dc.contributor.author | Drevets, W. | |
dc.date.accessioned | 2014-11-26T08:26:57Z | |
dc.date.available | 2014-11-26T08:26:57Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Kaddurah-Daouk, R., Yuan, P., Boyle, S.H., Matson, W., Wang, Z., Zeng, Z.B., Zhu, H., Dougherty, G.G., Yao, J.K., Chen, G., Guitart, X., Carlson, P.J., Neumeister, A., Zarate, C., Krishnan, R.R., Manji, H.K., Drevets, W. (2012). Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Scientific Reports 2 : -. ScholarBank@NUS Repository. https://doi.org/10.1038/srep00667 | |
dc.identifier.issn | 20452322 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/109958 | |
dc.description.abstract | Targeted metabolomics provides an approach to quantify metabolites involved in specific molecular pathways. We applied an electrochemistry-based, targeted metabolomics platform to define changes in tryptophan, tyrosine, purine and related pathways in the depressed and remitted phases of major depressive disorder (MDD). Biochemical profiles in the cerebrospinal fluid of unmedicated depressed (n = 14; dMDD) or remitted MDD subjects (n = 14; rMDD) were compared against those in healthy controls (n = 18; HC). The rMDD group showed differences in tryptophan and tyrosine metabolism relative to the other groups. The rMDD group also had higher methionine levels and larger methionine-to- glutathione ratios than the other groups, implicating methylation and oxidative stress pathways. The dMDD sample showed nonsignificant differences in the same direction in several of the metabolic branches assessed. The reductions in metabolites associated with tryptophan and tyrosine pathways in rMDD may relate to the vulnerability this population shows for developing depressive symptoms under tryptophan or catecholamine depletion. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1038/srep00667 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE | |
dc.description.doi | 10.1038/srep00667 | |
dc.description.sourcetitle | Scientific Reports | |
dc.description.volume | 2 | |
dc.description.page | - | |
dc.identifier.isiut | 000308863400001 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.